- Media Releases
- Research
- |
High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals
Summary:
| Citation | Blomqvist, Åke, and Rosalie Wyonch. 2019. High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals. ###. Toronto: C.D. Howe Institute. |
| Page Title: | High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals – C.D. Howe Institute |
| Article Title: | High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals |
| URL: | https://cdhowe.org/publication/high-drug-prices-big-rd-spenders-and-free-riders-canada-topsy-turvy-world-pharmaceuticals/ |
| Published Date: | February 26, 2019 |
| Accessed Date: | May 15, 2026 |
Outline
Outline
Related Topics
For all media inquiries, including requests for reports or interviews:
Canada is not a “free rider” on drug pricing according to a new report from the C.D. Howe Institute. In “High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals”, authors Åke Blomqvist and Rosalie Wyonch find that relative to its peers, Canada does not free ride on US research and development spending.
Related Publications
- Podcasts
Tammy Schirle
- Intelligence Memos
Colin Busby, Kate Koplovich, Alexandre Laurin
- Research
Thorsten Koeppl
- Intelligence Memos
Nicholas Dahir, Don Drummond, William B.P. Robson